|
lysosome organization
|
GO:0007040 |
21 |
0.991
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.972
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.972
|
|
|
glycosphingolipid catabolic process
|
GO:0046479 |
5 |
0.967
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.930
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.914
|
|
|
male courtship behavior
|
GO:0008049 |
2 |
0.895
|
Mouse |
|
glycolipid catabolic process
|
GO:0019377 |
5 |
0.877
|
|
|
liposaccharide metabolic process
|
GO:1903509 |
27 |
0.866
|
|
|
membrane lipid catabolic process
|
GO:0046466 |
8 |
0.850
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.831
|
Mouse |
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.685
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.673
|
|
|
fertilization
|
GO:0009566 |
127 |
0.614
|
Mouse |
|
courtship behavior
|
GO:0007619 |
5 |
0.587
|
Mouse |
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.561
|
Mouse |
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.557
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.442
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.440
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.424
|
Mouse |
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.396
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.378
|
|
|
oligosaccharide metabolic process
|
GO:0009311 |
11 |
0.364
|
Mouse |
|
oligosaccharide catabolic process
|
GO:0009313 |
2 |
0.345
|
Mouse |
|
ceramide catabolic process
|
GO:0046514 |
7 |
0.330
|
|
|
myelination
|
GO:0042552 |
74 |
0.312
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.310
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.296
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.288
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.281
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.273
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.269
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.258
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.257
|
Mouse |
|
single fertilization
|
GO:0007338 |
82 |
0.245
|
Mouse |
|
maintenance of location
|
GO:0051235 |
89 |
0.245
|
|
|
neuromuscular process controlling posture
|
GO:0050884 |
14 |
0.221
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.197
|
Mouse |
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.193
|
Mouse |
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.192
|
Mouse |
|
organelle assembly
|
GO:0070925 |
177 |
0.177
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.176
|
Mouse |
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.174
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.174
|
Mouse |
|
sensory perception
|
GO:0007600 |
245 |
0.164
|
|
|
adult walking behavior
|
GO:0007628 |
41 |
0.157
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.156
|
Mouse |
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.154
|
|
|
mating
|
GO:0007618 |
27 |
0.148
|
Mouse |
|
action potential
|
GO:0001508 |
78 |
0.148
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.137
|
Mouse |
|
natural killer cell degranulation
|
GO:0043320 |
3 |
0.137
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.128
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.128
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.127
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.127
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.120
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.110
|
Mouse |
|
axon ensheathment
|
GO:0008366 |
76 |
0.107
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.107
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.099
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.098
|
Mouse |
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.093
|
Mouse |
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.088
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.085
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.083
|
Mouse |
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.082
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.081
|
Mouse |
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.078
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.078
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.076
|
Mouse |
|
multi organism behavior
|
GO:0051705 |
62 |
0.072
|
Mouse |
|
immune effector process
|
GO:0002252 |
321 |
0.072
|
|
|
kidney development
|
GO:0001822 |
213 |
0.068
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.067
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.066
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.060
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.060
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.057
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.055
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.055
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.054
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.053
|
Mouse |
|
gland development
|
GO:0048732 |
330 |
0.052
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.049
|
Mouse |
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.049
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.048
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.047
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.045
|
Mouse |
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.044
|
|
|
n acetylglucosamine metabolic process
|
GO:0006044 |
3 |
0.043
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.042
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.042
|
|
|
antigen processing and presentation of exogenous peptide antigen
|
GO:0002478 |
21 |
0.042
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.042
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.041
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.039
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.039
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.038
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.037
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.037
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.037
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.036
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.036
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.035
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.035
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.035
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.034
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.034
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.034
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.033
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.033
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.032
|
|
|
cell killing
|
GO:0001906 |
67 |
0.032
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.032
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.032
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.031
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.031
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.031
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.031
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.031
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.030
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.030
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.030
|
|
|
cell growth
|
GO:0016049 |
130 |
0.029
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.029
|
|
|
natural killer cell activation involved in immune response
|
GO:0002323 |
10 |
0.029
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.029
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.029
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.029
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.029
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.029
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.028
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.028
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.028
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.028
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.028
|
|
|
metanephric glomerular visceral epithelial cell development
|
GO:0072249 |
2 |
0.028
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.028
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.028
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.027
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.027
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.027
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.027
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.027
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.027
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.027
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.027
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.027
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.027
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.027
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.026
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.026
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.026
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.026
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.026
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.026
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.026
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.025
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.025
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.025
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.025
|
|
|
glycosphingolipid metabolic process
|
GO:0006687 |
18 |
0.025
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.025
|
Mouse |
|
inflammatory response
|
GO:0006954 |
244 |
0.025
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.025
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.025
|
|
|
regulation of vascular smooth muscle contraction
|
GO:0003056 |
1 |
0.024
|
|
|
lung development
|
GO:0030324 |
164 |
0.024
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.024
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.024
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.024
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.023
|
|
|
learning
|
GO:0007612 |
98 |
0.023
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.023
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.023
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.023
|
|
|
renal system development
|
GO:0072001 |
225 |
0.023
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.022
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.022
|
|
|
water soluble vitamin biosynthetic process
|
GO:0042364 |
3 |
0.022
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.022
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.022
|
|
|
sphingosine metabolic process
|
GO:0006670 |
4 |
0.022
|
|
|
regulation of regulated secretory pathway
|
GO:1903305 |
20 |
0.022
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.022
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.021
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.021
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class ii
|
GO:0019886 |
14 |
0.021
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.021
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.021
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.021
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.021
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.021
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.021
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.021
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.021
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.021
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.020
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.020
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.020
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.020
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.020
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.020
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.020
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.020
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.020
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.020
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.019
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.019
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.019
|
|
|
intracellular cholesterol transport
|
GO:0032367 |
3 |
0.019
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.019
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.019
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.019
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.019
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.019
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.019
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.018
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.018
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.018
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.018
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.018
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.018
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.018
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.018
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.018
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.018
|
|
|
phagolysosome assembly
|
GO:0001845 |
3 |
0.018
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.018
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.018
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.018
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.017
|
|
|
glycosylceramide metabolic process
|
GO:0006677 |
4 |
0.017
|
|
|
glucosamine containing compound metabolic process
|
GO:1901071 |
3 |
0.017
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.017
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.017
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.017
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.017
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.017
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.017
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.017
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.017
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.017
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.017
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.017
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.016
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.016
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.016
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.016
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.016
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.016
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.016
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.016
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.016
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.016
|
|
|
ketone catabolic process
|
GO:0042182 |
3 |
0.016
|
|
|
light adaption
|
GO:0036367 |
2 |
0.016
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.016
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.016
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.016
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.016
|
|
|
hypothalamic tangential migration using cell axon interactions
|
GO:0021856 |
3 |
0.016
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.016
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.015
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.015
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.015
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.015
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.015
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.015
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.015
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.015
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.015
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.015
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.015
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.015
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.015
|
|
|
intracellular sterol transport
|
GO:0032366 |
3 |
0.015
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.015
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.015
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.015
|
|
|
intracellular lipid transport
|
GO:0032365 |
3 |
0.015
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.015
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.015
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.014
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.014
|
|
|
regionalization
|
GO:0003002 |
337 |
0.014
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.014
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.014
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.014
|
|
|
pericardium development
|
GO:0060039 |
16 |
0.014
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.014
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.014
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.014
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.014
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.014
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.014
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.014
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.014
|
|
|
substrate dependent cell migration cell extension
|
GO:0006930 |
4 |
0.014
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.014
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.013
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.013
|
|
|
regulation of natural killer cell mediated cytotoxicity
|
GO:0042269 |
19 |
0.013
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.013
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.013
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.013
|
|
|
blastocyst hatching
|
GO:0001835 |
4 |
0.013
|
|
|
synaptic vesicle priming
|
GO:0016082 |
8 |
0.013
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.013
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.013
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.013
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.013
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.013
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.013
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.013
|
|
|
ossification
|
GO:0001503 |
216 |
0.013
|
|
|
visual behavior
|
GO:0007632 |
45 |
0.013
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.013
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.013
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.013
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.013
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.013
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.013
|
|
|
regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling
|
GO:0003027 |
1 |
0.013
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.013
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.013
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.013
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.012
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.012
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.012
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.012
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.012
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.012
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.012
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.012
|
|
|
appendage development
|
GO:0048736 |
166 |
0.012
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.012
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.012
|
|
|
l ascorbic acid metabolic process
|
GO:0019852 |
4 |
0.012
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.012
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.012
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.012
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.012
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.012
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.012
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.012
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.012
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.012
|
|
|
response to drug
|
GO:0042493 |
75 |
0.012
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.012
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.012
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.012
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.012
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.012
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.012
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.012
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.012
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.012
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.012
|
|
|
organelle transport along microtubule
|
GO:0072384 |
14 |
0.012
|
|
|
ear development
|
GO:0043583 |
200 |
0.012
|
|
|
sphingolipid catabolic process
|
GO:0030149 |
7 |
0.012
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.011
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.011
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.011
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.011
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.011
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.011
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.011
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.011
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.011
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.011
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.011
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.011
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.011
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.011
|
|
|
synaptic vesicle docking involved in exocytosis
|
GO:0016081 |
4 |
0.011
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.011
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.011
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
hatching
|
GO:0035188 |
4 |
0.011
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.011
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.011
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.011
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.011
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.011
|
|
|
positive regulation of epithelial cell differentiation involved in kidney development
|
GO:2000698 |
2 |
0.011
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.011
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.011
|
|
|
membrane protein proteolysis
|
GO:0033619 |
10 |
0.011
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.011
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.011
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.011
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.011
|
|
|
homeostasis of number of cells within a tissue
|
GO:0048873 |
25 |
0.011
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.011
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.011
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.011
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.011
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.011
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.011
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.011
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.010
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.010
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.010
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.010
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.010
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.010
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.010
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.010
|
|
|
limb development
|
GO:0060173 |
166 |
0.010
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.010
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.010
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.010
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.010
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.010
|
|
|
lysosomal transport
|
GO:0007041 |
10 |
0.010
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.010
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.010
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.010
|
|
|
bone development
|
GO:0060348 |
120 |
0.010
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.010
|
|